Cannabinoid Receptor
The cannabinoid receptor (CB1 and CB2) is a member of G-protein coupled receptor which plays a significant role in physiologic processes such as cognitive and immune functions.
Products Related to Cannabinoid Receptor(111)
- GC17205CP-945598 HClCAS: 686347-12-6Purity: >98%
CP-945598 HCl is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor.
- GC10753(S)-SLV 319CAS: 464213-10-3Purity: >98%
(S)-SLV 319 (SLV319) is a potent, selective and orally active antagonist of cannabinoid CB1 receptor, with a Ki of 7.8 nM.
- GC10907(±)-SLV 319CAS: 362519-49-1Purity: >99.50%
(±)-SLV 319 ((±)-SLV319) is the racemate of SLV319.
- GC11849Arachidonyl serotoninCAS: 187947-37-1Purity: >98.00%
Arachidonyl serotonin (Arachidonyl serotonin; AA-5-HT) is a potent fatty acid amide hydrolase (FAAH) inhibitor with an IC50 value of 1~12 μM.
- GC12978Tocrifluor T1117CAS: 1186195-59-4Purity: >98%
Tocrifluor T1117 (T1117), a fluorescent form of the cannabinoid CB1 receptor antagonist AM251, is a selective fluorescent GPR55 ligand.
- GC13190R-Palmitoyl-(1-methyl) EthanolamideCAS: 142128-47-0Purity: >98.00%
synthetic analog of palmitoyl ethanolamide (PEA)
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10664 | Org 27569 | 868273-06-7 | >99.50% | |
Cannabinoid CB1 receptor allosteric modulator | ||||
| GC11376 | BML-190 | 2854-32-2 | >99.00% | |
CB2 receptor ligand | ||||
| GC11760 | GW842166X | 666260-75-9 | >99.50% | |
Cannabinoid receptor agonist | ||||
| GC15414 | AM1241 | 444912-48-5 | >98% | |
AM1241 is an aminoalkylindole analog and a selective ligand for the type II cannabinoid receptor (CB2), exhibiting higher affinity for the CB2 receptor (K i =3.4nM) than for the CB1 receptor (K i =280nM). | ||||
| GC15717 | AM251 | 183232-66-8 | >98.50% | |
AM251 is a cannabinoid receptor type 1 (CB1) antagonist with an IC 50 of 8nM and a G protein-coupled receptor 55 (GPR55) agonist with an EC 50 of 39nM. | ||||
| GC17205 | CP-945598 HCl | 686347-12-6 | >98% | |
CP-945598 HCl is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor. | ||||
| GC17259 | Rimonabant | 168273-06-1 | >98% | |
CB1 receptor antagonist | ||||
| GC10028 | (R)-SLV 319 | 656827-86-0 | >98% | |
CB1 receptor antagonist | ||||
| GC10032 | SR 144528 | 192703-06-3 | >98.00% | |
SR 144528 is a highly potent, selective, and orally active antagonist for the CB2 receptor, with a K i value of 0.6nM. | ||||
| GC10147 | AM630 | 164178-33-0 | >98.00% | |
AM630 is a potent and selective CB 2 receptor inverse agonist. | ||||
| GC10205 | Arvanil | 128007-31-8 | >98.00% | |
Cannabinoid CB1 and vanilloid TRPV1 (VR1) agonist | ||||
| GC10646 | TC-C 14G | 656804-72-7 | >98% | |
CB1 receptor inverse agonist | ||||
| GC10753 | (S)-SLV 319 | 464213-10-3 | >98% | |
(S)-SLV 319 (SLV319) is a potent, selective and orally active antagonist of cannabinoid CB1 receptor, with a Ki of 7.8 nM. | ||||
| GC10843 | Otenabant | 686344-29-6 | >99.00% | |
| GC10907 | (±)-SLV 319 | 362519-49-1 | >99.50% | |
(±)-SLV 319 ((±)-SLV319) is the racemate of SLV319. | ||||
| GC11453 | ML-191 | 931695-79-3 | >98% | |
inhibitor of LPI-induced phosphorylation of ERK1/2 | ||||
| GC11849 | Arachidonyl serotonin | 187947-37-1 | >98.00% | |
Arachidonyl serotonin (Arachidonyl serotonin; AA-5-HT) is a potent fatty acid amide hydrolase (FAAH) inhibitor with an IC50 value of 1~12 μM. | ||||
| GC12420 | MAFP | 188404-10-6 | >98.00% | |
cPLA2 and iPLA2 inhibitor, potent FAAH inhibitor | ||||
| GC12538 | LH 21 | 611207-11-5 | >98% | |
silent CB1 antagonist | ||||
| GC12868 | S-2 Methanandamide | 157182-48-4 | >98% | |
potent CB1 receptor agonist | ||||
| GC12920 | Pregnenolone | 145-13-1 | >98.00% | |
steroid hormone | ||||
| GC12978 | Tocrifluor T1117 | 1186195-59-4 | >98% | |
Tocrifluor T1117 (T1117), a fluorescent form of the cannabinoid CB1 receptor antagonist AM251, is a selective fluorescent GPR55 ligand. | ||||
| GC13190 | R-Palmitoyl-(1-methyl) Ethanolamide | 142128-47-0 | >98.00% | |
synthetic analog of palmitoyl ethanolamide (PEA) | ||||
| GC13267 | NIDA 41020 | 502486-89-7 | >98% | |
CB1 receptor antagonist | ||||
